Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


US Circuit split on use of prescribing data: Supreme Court review next?

This article was originally published in Scrip

Executive Summary

A three-judge panel of the US Court of Appeals for the Second Circuit struck down a Vermont law restricting aggregators from selling their information about physicians' prescribing patterns to drug manufacturers, saying it unconstitutionally restricts commercial speech. The law was challenged by three healthcare research firms – IMS Health, the analytics firm SDI, Wolters Kluwer Health – and the PhRMA trade group (whose members use the data), which argued that the Vermont law – which banned the use of prescriber data for marketing unless the doctor consented - would hurt public access to healthcare information and violated commercial speech.




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts